Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 10751-10760 of 13618

Page
per page
  1. GSK 4112
    B7460 GSK 4112
    Target: Rev-Erb Receptors
    Summary: Rev-Erbα agonist
      insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL
  2. YIL 781
    B7551 YIL 781
    Summary: Ghrelin receptor antagonist
      <44.6 mg/mL
  3. AS 2034178
    B7735 AS 2034178
    Summary: GPR40 agonist
      <22.43 mg/mL
  4. NKY 80
    B7743 NKY 80
    Summary: adenylyl cyclase (AC) inhibitor
      Soluble in DMSO
  5. ICI 174,864
    B5020 ICI 174,864
    Summary: Selective δ opioid antagonist
      Soluble to 69.19 mg/mL
  6. CAL-101 (Idelalisib, GS-1101)
    A3005 CAL-101 (Idelalisib, GS-1101)
     8 Citation
    Target: PI3K
    Summary: PI3K inhibitor
  7. Aspirin (Acetylsalicylic acid)
    A4013 Aspirin (Acetylsalicylic acid)
    Summary: Cyclooxygenase (COX) inhibitor
  8. JNJ-26481585
    A4090 JNJ-26481585
     4 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Potent HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.2 mg/mL
  9. KW-2478
    A4062 KW-2478
    Target: HSP90
    Summary: Potent Hsp90 inhibitor, novel, non-ansamycin,
      ≥100 mg/mL
  10. Dabigatran
    A4077 Dabigatran
    Summary: A potent, reversible direct thrombin inhibitor with core bioactivity of inhibiting thrombus formation.
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O

Items 10751-10760 of 13618

Page
per page